Related references
Note: Only part of the references are listed.Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial
K. Behringer et al.
ANNALS OF ONCOLOGY (2012)
Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer
Joseph M. Letourneau et al.
CANCER (2012)
Impact of cancer therapies on ovarian reserve
Clarisa R. Gracia et al.
FERTILITY AND STERILITY (2012)
Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study
Marleen A. E. van der Kaaij et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
Bastian von Tresckow et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
Andreas Engert et al.
LANCET (2012)
How do you feel about fertility and parenthood? The voices of young female cancer survivors
Jessica R. Gorman et al.
JOURNAL OF CANCER SURVIVORSHIP (2012)
Current options for preservation of fertility in the male
Peter Holoch et al.
FERTILITY AND STERILITY (2011)
Pretreatment Serum Anti-Mullerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer
Richard A. Anderson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
A. La Marca et al.
HUMAN REPRODUCTION UPDATE (2010)
Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results
Christine Decanter et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
C. E. Kiserud et al.
BRITISH JOURNAL OF CANCER (2009)
Pregnancy in classic galactosemia despite undetectable anti-Mullerian hormone
Cynthia S. Gubbels et al.
FERTILITY AND STERILITY (2009)
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
S. Lie Fong et al.
HUMAN REPRODUCTION (2009)
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy
I. Biasoli et al.
ANNALS OF ONCOLOGY (2008)
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials
M. Sieniawski et al.
ANNALS OF ONCOLOGY (2008)
Undetectable serum anti-Mullerian hormone levels and occurrence of ongoing pregnancy
Timothee Fraisse et al.
FERTILITY AND STERILITY (2008)
Relationship of serum antimullerian hormone concentration to age at menopause
J. van Disseldorp et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Treatment-related risk factors for premature menopause following Hodgkin lymphoma
Marie L. De Bruin et al.
BLOOD (2008)
Anti-mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood
Robert D. van Beek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women
S. Tsepelidis et al.
HUMAN REPRODUCTION (2007)
Sensitivity as outcome measure of androgen replacement: the AMS scale
Lothar A. Heinemann et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's lymphoma study group
K Behringer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
KL Singh et al.
HUMAN REPRODUCTION UPDATE (2005)
The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency
C Moore et al.
EUROPEAN UROLOGY (2004)
Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men:: Significance of adequate reference values from proven fertile men
AM Andersson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)